ODDB.org: Open Drug Database

Zaltrap 100 mg/4 ml, concentré pour solution pour perfusion - Durchstechflasche(n)

Swissmedic Key	62676001	Registration Holder	Sanofi-Aventis (Suisse) SA
Name	Zaltrap 100 mg/4 ml, concentré pour solution pour perfusion	Date of registration	20.03.2013
		Introduction of Sequence	20.03.2013
ATC-Classification	Aflibercept (L01XX44)	Revision date
WHO	WHO-DDD	Valid until
Index Therapeuticus (BSV)	70000.	Show package size	Durchstechflasche(n)
Index Therapeuticus (Swissmedic)	07.16.10.	Description
Swissmedic categorie.	A
SL Eintrag	Yes	Indication
Information for professionals	IP	Consumer information
Ex-factory-Price	324.67	Limitation	Yes
Limitation text

Deductible	10 %	Consumer price	369.50
Feedback	FB
GTIN	7680626760019	Medication Code	Biotechnologika
Pharmacode	5575828	Disponibility

Composition

afliberceptum 100 mg, natrii dihydrogenophosphas monohydricus, dinatrii phosphas heptahydricus, natrii citras dihydricus et acidum citricum, natrii chloridum, acidum hydrochloridum ad pH, natrii hydroxidum ad pH, saccharum, polysorbatum 20, aqua ad iniectabile, q.s. ad solutionem pro 4 ml corresp. natrium 11.118 mg.

Packungsbestandteile

Galenic Form

concentré pour solution pour perfusion

Excipiens

Active Agent	Dose
Afliberceptum	100mg / 4ml

BAG: Active Agent	Dose
Afliberceptum	100 mg

Inactive agents
Acidum Citricum
Acidum Hydrochloridum ad Ph
Disodium Phosphate Heptahydrate
Sodium Chloride
Natrii Citras Dihydricus
Sodium Dihydrogenophosphate Monohydrate
Natrii Hydroxidum ad Ph
Polysorbatum 20
Saccharum

Source

Data was imported : 04.02.2026 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :

2026	©ywesee GmbH